文献速递鼻科

翼腭注射减少出血:一项系统综述与Meta分析

Reduction of Bleeding From Pterygopalatal Injection: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2025-01-01

该系统综述与Meta分析纳入7项随机临床试验共322例鼻窦炎患者,评估鼻内镜鼻窦手术中翼腭注射利多卡因与肾上腺素的疗效。结果显示,与对照组相比,翼腭注射可改善手术视野评分(BSFG合并SMD为-1.01,95%CI -1.72至-0.30)并显著降低平均动脉压(合并MD为-0.49 mm Hg,95%CI -0.91至-0.07),但出血量和手术时长无显著差异。作者认为翼腭注射可作为减少BSFG、改善手术视野的有效方法。

要点

  • 翼腭注射利多卡因与肾上腺素可改善鼻内镜鼻窦手术视野(BSFG合并SMD -1.01,95%CI -1.72至-0.30)。
  • 翼腭注射与平均动脉压显著降低相关(合并MD -0.49 mm Hg,95%CI -0.91至-0.07)。
  • 翼腭注射与出血量(合并MD -9.47 mL,95%CI -29.05至10.11)及手术时长(合并MD -4.28分钟,95%CI -12.85至4.29)无显著关联。

核心结论

  • 翼腭注射可作为鼻内镜鼻窦手术中减少BSFG、改善手术视野的有效方法,其效果通过显著改善手术视野和降低平均动脉压实现。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed/MEDLINE、Cochrane图书馆和EMBASE自建库至2024年7月31日的文献,纳入7项随机临床试验共322例鼻窦炎患者,研究在澳大利亚、加拿大、埃及、印度和伊朗进行。

主要发现

  • BSFG合并SMD为-1.01(95%CI -1.72至-0.30),提示翼腭注射利多卡因与肾上腺素与手术视野改善相关。
  • 平均动脉压合并MD为-0.49 mm Hg(95%CI -0.91至-0.07),提示翼腭注射与平均动脉压显著降低相关。
  • 出血量合并MD为-9.47 mL(95%CI -29.05至10.11),手术时长合并MD为-4.28分钟(95%CI -12.85至4.29),提示该技术与出血量或手术时长无显著关联。
  • 患者平均年龄范围为30至48.8岁,男性占研究人群的36.7%至66.7%。
  • 多数研究中BSFG观察时间以15分钟为间隔测量,测量时间从最短15分钟至最长150分钟。

关键数值与推荐

  • 纳入标准为:诊断为鼻窦炎的患者;干预为翼腭注射利多卡因与肾上腺素;对照为生理盐水或不注射;结局采用主观评分(Boezaart手术野分级[BSFG])和客观指标(出血量、手术时长和平均动脉压[MAP])。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Endoscopic sinus surgery (ESS) is a minimally invasive surgical method that is widely used in the treatment of various sinonasal conditions, including chronic sinusitis, nasal polyps, and fungal sinusitis. However, intraoperative bleeding remains a significant challenge. OBJECTIVE: To evaluate the effects of pterygopalatal injections with lidocaine and adrenaline during sinus surgery. DATA SOURCES: PubMed/MEDLINE, the Cochrane Library, and EMBASE were systematically searched from database inception through July 31, 2024. Two authors also manually and independently searched all relevant studies. STUDY SELECTION: Randomized clinical trials with (1) patients diagnosed with sinusitis; (2) interventions that included pterygopalatal injections with lidocaine and adrenaline; (3) comparisons that were specified as normal saline or no injection; and (4) outcomes that used subjective scores (Boezaart surgical field grading [BSFG]) and objective markers (amount of bleeding, duration of surgery, and mean arterial pressure [MAP]). DATA EXTRACTION AND SYNTHESIS: Data extraction was completed independently by 2 extractors and cross-checked for research integrity. The pairwise meta-analysis was performed to compare the treatment group with control used in ESS. Hedges g standardized mean differences (SMDs) and mean differences (MDs) were used for improvement in all outcomes. MAIN OUTCOMES AND MEASURES: Efficacy outcomes included subjective scores, such as BSFG, as well as objective markers measuring amount of bleeding, duration of surgery, and MAP. RESULTS: A comprehensive literature search identified 322 patients from 7 studies. The studies were conducted in Australia, Canada, Egypt, India, and Iran. The mean age range was 30 to 48.8 years, and 36.7% to 66.7% of the study populations were male. In most studies, the observation time of BSFG was measured at 15-minute intervals and measured from a minimum of 15 minutes to a maximum of 150 minutes. The pooled SMD for BSFG between treatments vs the control group was -1.01 (95% CI, -1.72 to -0.30), indicating that pterygopalatal injection with lidocaine and adrenaline was associated with improvement in the surgical field condition. The pooled MD for MAP between treatments vs the control group was -0.49 mm Hg (95% CI, -0.91 to -0.07), indicating that pterygopalatal injection was associated with significantly reduced MAP. The pooled MD for amount of bleeding between treatments vs the control group was -9.47 mL (95% CI, -29.05 to 10.11), and the pooled MD for duration of surgery between treatments vs the control group was -4.28 minutes (95% CI, -12.85 to 4.29), indicating that that this technique was not significantly associated with amount of bleeding or duration of surgery. CONCLUSIONS AND RELEVANCE: The findings of this systematic review and meta-analysis indicate that pterygopalatal injection can be an effective method for reducing BSFG during ESS to improve the surgical field. This can be achieved by significantly improving the surgical field of view and lowering MAP.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Shim SR, Shin J, Hwang CM, et al. Reduction of Bleeding From Pterygopalatal Injection: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 39946111. doi:10.1001/jamaoto.2024.5047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。